Development of polyneuropathy during thalidomide therapy
- 31 March 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 112 (4) , 475-480
- https://doi.org/10.1111/j.1365-2133.1985.tb02323.x
Abstract
Seven patients with prurigo nodularis and one with aphthous stomatitis were given 40–115 g of thalidomide for 1 to 6 years. They all developed a predominantly sensory peripheral neuropathy mainly involving the lower limbs. Five patients had an unpleasant tight feeling around the feet. Nerve conduction studies showed small sensory action potentials from the lower limbs with normal or only mild slowing of sensory conduction velocity indicating an axonal neuropathy. The dermatological disorder improved dramatically in all, but treatment had to be discontinued because of the severe side-effects. Thalidomide, if used, should be given only over a short period because of its neurotoxic effect.This publication has 16 references indexed in Scilit:
- Thalidomide neurotoxicityArchives of Dermatology, 1984
- Thalidomide: Use and possible mode of action in reactional lepromatous leprosy and in various other conditionsJournal of the American Academy of Dermatology, 1982
- Thalidomide treatment of subacute cutaneous lupus erythematosusBritish Journal of Dermatology, 1982
- The Treatment of Lepra Reaction In Lepromatous LeprosyInternational Journal of Dermatology, 1980
- Treatment of prurigo nodularis with thalidomideArchives of Dermatology, 1980
- Neuropathy after Thalidomide ("Distaval")BMJ, 1961
- Thalidomide NeuropathyBMJ, 1961
- Polyneuritische Syndrome nach längerer Thalidomid1-MedikationDeutsche Medizinische Wochenschrift (1946), 1961
- Bewirkt Thalidomid (Contergan®1) keine Schäden?Deutsche Medizinische Wochenschrift (1946), 1961
- Is Thalidomide to Blame?BMJ, 1960